KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Interest Coverage Ratio (2016 - 2026)

West Pharmaceutical Services has reported Interest Coverage Ratio over the past 18 years, most recently at 93.21 for Q1 2026.

  • Quarterly Interest Coverage Ratio fell 65.15% to 93.21 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 327.5 through Mar 2026, up 6.39% year-over-year, with the annual reading at 1169.8 for FY2025, 515.79% up from the prior year.
  • Interest Coverage Ratio was 93.21 for Q1 2026 at West Pharmaceutical Services, up from 783.0 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 1537.0 in Q2 2025 and troughed at 783.0 in Q4 2025.
  • The 5-year median for Interest Coverage Ratio is 84.64 (2022), against an average of 167.76.
  • Peak annual rise in Interest Coverage Ratio hit 1726.86% in 2025, while the deepest fall reached 292.48% in 2025.
  • Tracing WST's Interest Coverage Ratio over 5 years: stood at 76.29 in 2022, then surged by 75.75% to 134.08 in 2023, then plummeted by 248.79% to 199.5 in 2024, then crashed by 292.48% to 783.0 in 2025, then soared by 111.9% to 93.21 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 93.21, 783.0, and 838.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.